Acquired Blepharophimosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acquired Blepharophimosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT06514612

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose)…

A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops) used twice daily (BID)…

Czechia, France234 participantsStarted 2024-12-30

Treatment: STN1013800 (0.1% Oxymetazoline Hydrochloride) eye drops in single dose containers, Placebo (0% Oxymetazoline Hydrochloride) eye drops in single dose containers

Acquired Blepharophimosis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose)…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose)…

All recent trials (1 shown)